According to the latest information, Samsung Biologics secured the second position in the Most Trustworthy Companies in Healthcare and Life Services category globally, while Celltrion ranked 10th.
Samsung Biologics is a company that helps other big healthcare companies make important medical stuff. The company now work with 13 out of the top 20 healthcare companies in the world. Some of its recent big customers are Roche, Pfizer, and Novartis. Also, it opened new offices in San Francisco in 2020 and New Jersey this year, and the company is looking for more customers all around the world.
In this survey, Samsung Biologics scored high in its global network, and Celltrion received high marks for its Research & Development (R&D) and biosimilar product portfolio.
Celltrion recently received approval to sell its biosimilar, Vegzema (active ingredient bevacizumab, trade name Avastin) in Australia and has been granted sales licenses in 39 countries including the U.S., Europe, U.K., and Japan. Celltrion is working hard to achieve its goal of expanding its biosimilar product portfolio to 22 by 2030 by seeking sales license approvals in various countries worldwide.
(Via NewsWeek & Global market research firm Statista)